<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2005</Year><Month>01</Month><Day>28</Day></PubDate></Journal><title locale="en_US">A Comparison between Intravenous Magnesium Sulfate and Oral Magnesium Chloride in Mild Preeclampsia</title><FirstPage>6</FirstPage><LastPage>9</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Obstetrics and Gynecology, Isfahan University of Medical Sciences</affiliation></Author><Author><affiliation locale="en_US">Department of Obstetrics and Gynecology, Isfahan University of Medical Sciences</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2006</Year><Month>08</Month><Day>15</Day></PubDate><PubDate PubStatus="accepted"><Year>2006</Year><Month>08</Month><Day>15</Day></PubDate></History><abstract locale="en_US">Background: Preeclampsia is the second cause of maternal mortality in the United States and accounts for 25% of perinatal&#13;
mortality. Mild Preeclampsia could be treated without hospitalization, however in some cases, hospitalization seems necessary.&#13;
Administration of magnesium sulfate (MgSo4) in mild preeclampsia is a matter of controversy.&#13;
It is obvious that replacing intravenous magnesium sulfate with an oral preparation of magnesium, of course if it gains a&#13;
sufficiently high serum level, can be easier to use and less expensive. Up to the present time, we have not been able to find any&#13;
previously done studies using oral magnesium preprations to treat preeclampsia. Thus, we tried to compare serum magnesium&#13;
level with oral magnesium chloride and intravenous (IV) magnesium sulfate therapy.&#13;
Methods: This was a comparative experimental study. From January 2002 until April 2003, pregnant patients with mild preeclampsia&#13;
admitted to Al-Zahra and Beheshti hospitals,Isfahan,Iran, between their 27th and 38th weeks of gestation were divided&#13;
into 2 groups randomly. There were 33 patients in each group. The first group was treated with IV magnesium sulfate (2&#13;
g/h) and the second group received oral magnesium chloride (4 g/2h). Magnesium level was checked in 0, 3, 6, 12 hours. The&#13;
collected data were analyzed with t-Student test on a computer applying SPSS software.&#13;
Results: There was no statistical difference between the two groups regarding age, gravidity and gestational age. Magnesium&#13;
level rose in both groups (P&lt;0.01).&#13;
Increase of magnesium level in IV magnesium sulfate group was greater than in the other group, and in the magnesium&#13;
chloride group, therapeutic level could not be achieved.&#13;
Conclusion: Increase of serum Mg level in IV Mg sulfate group and reaching the therapeutic level was the same as reported&#13;
before. Increase of Mg level with oral Mg chloride, though measurable, did not reach the therapeutic level. Perhaps with more&#13;
cases or higher amounts of the drug or other types of Mg preparations we could reach the therapeutic level.&#13;
Keywords: Preeclampsia, Serum magnesium level, Magnesium chloride, Pregnancy Induced Hypertension (PIH), Oral administration</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/343</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/343/129</pdf_url></Article></Articles>
